Tupelo Data Room
Other Health Care & Fitness, Pharmacies
Active

Established Specialty Pharmacy with Strong Growth Potential

New York, United States
Asking Price$15m
Revenue$25.83m
EBITDA-
Cash Flow$2.50m
Description
Two package deal!! An exclusive opportunity is now available to acquire a well-established specialty pharmacy, founded in 2004. With a strong reputation, loyal customer base, and prime market position, this pharmacy is poised for continued success and growth. Key Business Highlights: Prime Location & Facility: Located in a high-traffic area, this 10,000 sq. ft. facility dispenses an average of 700 prescriptions daily, offering excellent operational efficiency. Solid Revenue Streams: The business holds contracts with all major insurance carriers, a 340B contract, and a wholesale license, ensuring a smooth transition for an experienced operator or investor. Expanded Service Offerings: A newly executed collaborative agreement with a 340B doctor allows for the testing and prescribing of HIV medications, significantly expanding the pharmacy’s service capabilities. Strategic Synergy: There’s an opportunity to merge with a neighboring business (Poppies), resulting in reduced overhead costs such as rent, payroll, and licensing. Owner Transition: The majority owner is retiring, and the minority owner is working part-time while exploring other ventures, making this a perfect opportunity for a new owner to take full control of the business. This is a rare and lucrative chance to enter or expand within the fast-growing specialty pharmacy sector with a profitable, well-managed business. For more information and to discuss next steps, please contact us today.
Real Estate
Leased
Building Size: 10000 sq. ft.
Furniture Fixtures & Equipment
$200k
Inventory
$1m
Number of EmployeesFull-Time: 17
Year Established
2004
Reason Selling
Retiring and other business interests.
Facilities & Assets
10,000 square feet recently remodeled.
Support & Training
Owner is willing stay for a smooth transition.
Growth Opportunities
Expand with other drugs and more doctors using the 340B.
Asking Price$15m